{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:55:43Z","timestamp":1781528143890,"version":"3.54.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.msard.2026.107141","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:17:15Z","timestamp":1773505035000},"page":"107141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["High burden of poor prognostic factors at first presentation in treatment-na\u00efve relapsing multiple sclerosis: Real-world evidence from a large Egyptian cohort"],"prefix":"10.1016","volume":"109","author":[{"given":"Nada","family":"Nasr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farouk","family":"Talaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Ramdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa","family":"Elsalamawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermeen","family":"Nabil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hossam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya Abdel","family":"Galeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5004-7454","authenticated-orcid":false,"given":"Eman","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.msard.2026.107141_bib0018","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jamaneurol.2021.3416","article-title":"Health disparities, inequities, and social determinants of Health in Multiple sclerosis and related disorders in the US: a review","volume":"78","author":"Amezcua","year":"2021","journal-title":"JAMa Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107141_bib0034","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamaneurol.2019.0330","article-title":"Changes in the risk of reaching multiple sclerosis disability milestones In recent decades: a nationwide population-based cohort study in Sweden","volume":"76","author":"Beiki","year":"2019","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107141_bib0003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2019.01.045","article-title":"Prognostic factors of disability in relapsing remitting multiple sclerosis","volume":"30","author":"Briggs","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2026.107141_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158978","article-title":"Long term clinical prognostic factors in relapsing-remitting multiple sclerosis: insights from a 10-year observational study","volume":"11","author":"Bsteh","year":"2016","journal-title":"PLoS. One"},{"issue":"12","key":"10.1016\/j.msard.2026.107141_bib0010","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1007\/s00415-019-09589-2","article-title":"Early MRI predictors of prognosis in multiple sclerosis","volume":"266","author":"Davda","year":"2019","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107141_bib0002","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00415-006-0095-1","article-title":"Clinical characteristics and long term prognosis in early onset multiple sclerosis","volume":"253","author":"Deryck","year":"2006","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107141_bib0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/cjn.2015.302","article-title":"Balancing early aggression against risk of progression in multiple sclerosis","volume":"43","author":"Duquette","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.msard.2026.107141_bib0013","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1007\/s00415-022-11193-w","article-title":"Early use of high-efficacy diseasemodifying therapies makes the difference in people with multiple sclerosis: an expert opinion","volume":"269","author":"Filippi","year":"2022","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.msard.2026.107141_bib0043","first-page":"113","article-title":"Multiple Sclerosis Registry in Germany: results of the extension phase 2005\/2006","volume":"105","author":"Flachenecker","year":"2008","journal-title":"Dtsch. Arztebl. Int."},{"issue":"6","key":"10.1016\/j.msard.2026.107141_bib0001","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1155\/2013\/484959","article-title":"MRI, and CSF markers of disability progression in multiple sclerosis","volume":"35","author":"Gajofatto","year":"2013","journal-title":"Dis. Markers"},{"issue":"3","key":"10.1016\/j.msard.2026.107141_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246157","article-title":"The nature of genetic and environmental susceptibility to multiple sclerosis","volume":"16","author":"Goodin","year":"2021","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.msard.2026.107141_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-094688","article-title":"OFSEP-HD investigators. Prognostic factors of disability progression in multiple sclerosis in real life: the OFSEP-high definition (OFSEP-HD) prospective cohort in France","volume":"15","author":"Guillemin","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.msard.2026.107141_bib0025","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2147\/NDT.S140869","article-title":"Characteristics and predictors of progression in an Egyptian multiple sclerosis cohort: a multicenter registry study","volume":"13","author":"Hamdy","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"3","key":"10.1016\/j.msard.2026.107141_bib0046","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/0004-282x20170010","article-title":"Malignant multiple sclerosis: clinical and demographic prognostic factors","volume":"75","author":"Hampshire-Ara\u00fajo","year":"2017","journal-title":"Arq. Neuropsiquiatr."},{"issue":"5","key":"10.1016\/j.msard.2026.107141_bib0014","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jamaneurol.2018.4905","article-title":"Clinical outcomes of escalation vs early intensive disease-modifying therapy in patients with multiple sclerosis","volume":"76","author":"Harding","year":"2019","journal-title":"JAMa Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107141_bib0012","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1177\/13524585211033190","article-title":"Paradigm shifts: early initiation of high-efficacy disease-modifying treatment in multiple sclerosis","volume":"27","author":"Hartung","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107141_bib0037","article-title":"Assessment of definitions of sustained disease progression in relapsing-remitting multiple sclerosis","volume":"2013","author":"Healy","year":"2013","journal-title":"Mult. Scler. Int."},{"issue":"1","key":"10.1016\/j.msard.2026.107141_bib0045","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00415-025-13536-9","article-title":"Determinants and prognostic value of onset symptoms in multiple sclerosis","volume":"273","author":"Hedstr\u00f6m","year":"2025","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107141_bib0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jnnp-2011-301051","article-title":"The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry","volume":"83","author":"Hughes","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2026.107141_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ncl.2023.07.001","article-title":"Multiple sclerosis diagnostic delay and misdiagnosis","volume":"42","author":"Kaisey","year":"2024","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2026.107141_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104271","article-title":"Multiple sclerosis diagnostic delay and its associated factors in upper Egyptian patients","volume":"71","author":"Khedr","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2026.107141_bib0031","article-title":"The topographical model of MS: empirical evaluation of the recapitulation hypothesis","volume":"4","author":"Laitman","year":"2018","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"9","key":"10.1016\/j.msard.2026.107141_bib0033","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1111\/ene.15422","article-title":"Disability progression in multiple sclerosis patients using early first-line treatments","volume":"29","author":"Lefort","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107141_bib0041","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1111\/ene.15422","article-title":"Disability progression in multiple sclerosis patients using early first-line treatments","volume":"29","author":"Lefort","year":"2022","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.msard.2026.107141_bib0036","doi-asserted-by":"crossref","unstructured":"Liu P.J., Yuan P., Liu S.P. Baseline expanded disability status scale score and CD8 + T cell levels as risk factors for disability progression in multiple sclerosis. Published online 2025. doi:10.2147\/JIR.S540152.","DOI":"10.2147\/JIR.S540152"},{"issue":"4","key":"10.1016\/j.msard.2026.107141_bib0019","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0000000000007837","article-title":"Multiple sclerosis in resource-limited settings: research opportunities in an unequal world","volume":"93","author":"Mateen","year":"2019","journal-title":"Neurology."},{"issue":"2","key":"10.1016\/j.msard.2026.107141_bib0028","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.61.2.217","article-title":"Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis","volume":"61","author":"Minneboo","year":"2004","journal-title":"Arch. Neurol."},{"issue":"10","key":"10.1016\/j.msard.2026.107141_bib0022","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.msard.2026.107141_bib0009","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/sj.sc.3101798","article-title":"Clinical characteristics, course and prognosis of spinal multiple sclerosis","volume":"43","author":"Nociti","year":"2005","journal-title":"Spinal Cord."},{"issue":"11\u201312","key":"10.1016\/j.msard.2026.107141_bib0038","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/13524585241275471","article-title":"Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model","volume":"30","author":"Ocampo","year":"2024","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2026.107141_bib0016","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrneurol.2016.187","article-title":"Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis","volume":"13","author":"Olsson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2026.107141_bib0011","unstructured":"Prognostic factors in MS: key insights | practical neurology, 2022. Accessed February 13, 2026. https:\/\/practicalneurology.com\/diseases-diagnoses\/ms-immune-disorders\/prognostic-factors-in-multiple-sclerosis\/31874\/."},{"issue":"1","key":"10.1016\/j.msard.2026.107141_bib0027","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12883-025-04172-x","article-title":"Multiple sclerosis patients\u2019 journey delay in diagnosis and treatment: a multicenter study","volume":"25","author":"Ragab","year":"2025","journal-title":"BMC. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107141_bib0006","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ncl.2011.01.006","article-title":"Natural history of multiple sclerosis: long-term prognostic factors","volume":"29","author":"Renoux","year":"2011","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.msard.2026.107141_bib0008","article-title":"Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis","volume":"44","author":"Rocca","year":"2024","journal-title":"Lancet Reg. Health - Eur."},{"issue":"Pt 1","key":"10.1016\/j.msard.2026.107141_bib0044","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/brain\/116.1.117","article-title":"Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up","volume":"116","author":"Runmarker","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107141_bib0039","unstructured":"The Italian Multiple Sclerosis Register, 2021. Accessed February 13, 2026. https:\/\/registroitalianosm.it\/en\/index.php?page=projectdetails&idproj=42."},{"issue":"2","key":"10.1016\/j.msard.2026.107141_bib0023","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"Pt 7","key":"10.1016\/j.msard.2026.107141_bib0005","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2026.107141_bib0029","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1212\/WNL.47.6.1469","article-title":"Accumulation of hypointense lesions (\u201cblack holes\u201d) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis","volume":"47","author":"Truyen","year":"1996","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2026.107141_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.991291","article-title":"Using personalized prognosis in the treatment of relapsing multiple sclerosis: a practical guide","volume":"13","author":"Van Wijmeersch","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107141_bib0007","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.msard.2016.03.011","article-title":"Prognostic factors associated with long-term disability and secondary progression in patients with Multiple Sclerosis","volume":"8","author":"Vasconcelos","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2026.107141_bib0042","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40120-025-00726-w","article-title":"Long-term management and therapeutic sequencing for patients with relapsing multiple sclerosis in France: a Vignette study","volume":"14","author":"Vermersch","year":"2025","journal-title":"Neurol. Ther."},{"issue":"9","key":"10.1016\/j.msard.2026.107141_bib0017","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/acn3.50862","article-title":"Environmental and genetic risk factors for MS: an integrated review","volume":"6","author":"Waubant","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107141_bib0030","article-title":"Cerebellar and\/or brainstem lesions indicate poor prognosis in Multiple sclerosis: a systematic review","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107141_bib0024","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.msard.2016.06.013","article-title":"Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt","volume":"10","author":"Zakaria","year":"2016","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:23:54Z","timestamp":1781526234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482600177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S221103482600177X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107141","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High burden of poor prognostic factors at first presentation in treatment-na\u00efve relapsing multiple sclerosis: Real-world evidence from a large Egyptian cohort","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107141"}}